We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Decision type
- Cancelled under Section 41GL(d) of the Act (34095)
- Cancelled under Section 30(1)(c) of the Act (25167)
- Cancelled under s41GL(d) of the Act (6234)
- Cancelled under s30(1)(c) (2683)
- Cancelled under s30(1)(c) of the Act (1775)
- Cancelled under s41GL(d) (1375)
- Cancelled under s30(1)(c ) (782)
- Cancelled at the request of the sponsor (673)
- Cancelled under s30(1) (321)
- Section 41GL(d) of the Act (202)
- Cancelled under Section 30(1)(a) of the Act (110)
- Cancelled under Section 41GL(d) (90)
- Cancelled under 41GL(d) (89)
- Cancelled under S30(1) (89)
- Cancelled under Section 32GA(1)(d) of the Act (5)
Search
73690 result(s) found, displaying 7326 to 7350
-
Cancellation by sponsorRequested by Sandoz Pty Ltd
-
Cancellation by sponsorRequested by ZimVie Australia Pty Ltd
-
Cancellation by sponsorRequested by ZimVie Australia Pty Ltd
-
Cancellation by sponsorRequested by Australian Nuclear Science and Technology Organisation T/A ANSTO
-
Cancellation by sponsorRequested by Australian Nuclear Science and Technology Organisation T/A ANSTO
-
Cancellation by sponsorRequested by Australian Nuclear Science and Technology Organisation T/A ANSTO
-
Cancellation by sponsorRequested by Australian Nuclear Science and Technology Organisation T/A ANSTO
-
Cancellation by sponsorRequested by Australian Nuclear Science and Technology Organisation T/A ANSTO
-
Cancellation by sponsorRequested by Australian Nuclear Science and Technology Organisation T/A ANSTO
-
ARI Sodium Iodide (131I) 20,000MBq/mL oral solution vial Cancelled under Section 30(1)(c) of the Act
Cancellation by sponsorRequested by Australian Nuclear Science and Technology Organisation T/A ANSTO -
Cancellation by sponsorRequested by Australian Nuclear Science and Technology Organisation T/A ANSTO
-
ARI SODIUM IODIDE(I123) 1-12 MBq DIAGNOSTIC CAPSULE vial Cancelled under Section 30(1)(c) of the Act
Cancellation by sponsorRequested by Australian Nuclear Science and Technology Organisation T/A ANSTO -
Cancellation by sponsorRequested by Biotronik Australia Pty Ltd
-
Cancellation by sponsorRequested by Boston Scientific Pty Ltd
-
Cancellation by sponsorRequested by Boston Scientific Pty Ltd
-
Cancellation by sponsorRequested by Sandoz Pty Ltd
-
Cancellation by sponsorRequested by Sandoz Pty Ltd
-
Cancellation by sponsorRequested by Dentsply Sirona Pty Ltd
-
Cancellation by sponsorRequested by FB Dermatology Pty Ltd
-
Cancellation by sponsorRequested by Australian Nuclear Science and Technology Organisation T/A ANSTO
-
Cancellation by sponsorRequested by Herbal Supplies Pty Ltd
-
Cancellation by sponsorRequested by Australian Nuclear Science and Technology Organisation T/A ANSTO
-
Cancellation by sponsorRequested by Midmed Pty Ltd
-
Cancellation by sponsorRequested by Midmed Pty Ltd
-
Cancellation by sponsorRequested by Australian Nuclear Science and Technology Organisation T/A ANSTO
Last updated